Literature DB >> 20068435

Botulinum toxin a injection into calf muscles for treatment of spastic equinus in cerebral palsy: a controlled trial comparing sonography and electric stimulation-guided injection techniques: a preliminary report.

Jeong-Yi Kwon1, Ji Hye Hwang, Joon-Sung Kim.   

Abstract

OBJECTIVE: To compare the clinical outcomes of two different injection techniques, one guided by electric stimulation and the other by sonography, for botulinum toxin A injection into calf muscles for the treatment of spastic equinus in children with cerebral palsy.
DESIGN: Thirty-two children with cerebral palsy with spastic equinus gait were enrolled in separate categories according to their level under the Gross Motor Function Classification System and divided into two groups with alternate allocation: sonography-guided group and electric stimulation-guided group. Equal amounts of botulinum toxin A were injected into the gastrocnemius at four to six points in 30 children with cerebral palsy. The injection was guided by electric stimulation in 14 and by ultrasonography in 16 children. Modified Ashworth Scale, Modified Tardieu Scale, Selective Motor Control, and Physician's Rating Scale were measured at baseline, 1 mo, and 3 mos posttreatment.
RESULTS: Subscales of the Physician's Rating Scale (gait pattern and hindfoot position-maximum foot/floor contact during stance) significantly improved in the sonography-guided group. No statistical differences were noted in Modified Ashworth Scale, Modified Tardieu Scale, and Selective Motor Control.
CONCLUSIONS: Visual feedback by ultrasonography could improve the accuracy of selective neuromuscular blocking of the gastrocnemius.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20068435     DOI: 10.1097/PHM.0b013e3181ca24ac

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  8 in total

1.  Comparison of surface and ultrasound localization to identify forearm flexor muscles for botulinum toxin injections.

Authors:  M Kristi Henzel; Michael C Munin; Christian Niyonkuru; Elizabeth R Skidmore; Douglas J Weber; Ross D Zafonte
Journal:  PM R       Date:  2010-07       Impact factor: 2.298

Review 2.  Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity.

Authors:  Andrea Santamato; Francesco Panza
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

3.  Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey.

Authors:  Nicola Smania; Carlo Colosimo; Anna Rita Bentivoglio; Giorgio Sandrini; Alessandro Picelli
Journal:  Funct Neurol       Date:  2013 Oct-Dec

Review 4.  Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy.

Authors:  Francesco C Blumetti; João Carlos Belloti; Marcel Js Tamaoki; José A Pinto
Journal:  Cochrane Database Syst Rev       Date:  2019-10-08

Review 5.  Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement.

Authors:  Axel Schramm; Tobias Bäumer; Urban Fietzek; Susanne Heitmann; Uwe Walter; Wolfgang H Jost
Journal:  J Neural Transm (Vienna)       Date:  2014-12-30       Impact factor: 3.575

6.  Efficacy of two injection-site localisation techniques for botulinum toxin injections: a single-blind, crossover, randomised trial protocol among adults with hemiplegia due to stroke.

Authors:  Claire Morel; Isabelle Hauret; Nicolas Andant; Armand Bonnin; Bruno Pereira; Emmanuel Coudeyre
Journal:  BMJ Open       Date:  2016-11-15       Impact factor: 2.692

Review 7.  Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures.

Authors:  Katharine E Alter; Barbara I Karp
Journal:  Toxins (Basel)       Date:  2017-12-28       Impact factor: 4.546

Review 8.  Over 25 Years of Pediatric Botulinum Toxin Treatments: What Have We Learned from Injection Techniques, Doses, Dilutions, and Recovery of Repeated Injections?

Authors:  Heli Sätilä
Journal:  Toxins (Basel)       Date:  2020-07-06       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.